Full Description
Tumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints scientists and science interns with the fundamental knowledge of the experimental aspects and state-of-the-art technology for vesicular carriers to equip their rational application in tumor targeting, but also provides a holistic understanding of regulatory concerns, patents, and clinical trials. In 15 chapters. this book provides basics and advances in stimuli-responsive vesicular carriers for tumor targeting based on findings outlined in highly organized tables, illustrative figures, and flow charts.
With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumors, drug delivery approaches, and associated challenges, it helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer.
Contents
1. Anomalous tumor microenvironment: exploitable features for drug delivery
2. Vesicular carriers for stimuli-responsive drug delivery to tumors: design considerations
3. Role of dePEGylation in vesicular carriers mediated stimuli-responsive drug delivery to tumors
4. pH-responsive vesicular carriers as promising tools for tumor targeting
5. Enzyme-responsive vesicular carriers as an emerging approach for tumor targeting
6. Redox-responsive vesicular carriers for potential tumor-targeting applications
7. Hypoxia-responsive vesicular carriers for enhanced tumor targeting
8. Magnetically responsive and thermo-responsive vesicular carriers for improved drug delivery to tumors
9. Cancer Therapy with Vesicular Drug Delivery System and Ultrasound Assistance
10. Light-triggered vesicular carriers for tumor targeting
11. Electro- and Mechano-responsive vesicular carriers targeting tumors
12. Emerging applications of stimuli-responsive novel vesicular carriers: Exosomes, supramolecular vesicles, and catanionic vesicles
13. Vesicular carriers with multipronged features for diagnostics and theranostics
14. Nanotoxicity and challenges in stimuli-responsive vesicular carriers targeting tumor
15. Patents, clinical trials, and regulatory concerns with stimuli-responsive vesicular carriers.
